Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 439

Results For "ABLE"

4875 News Found

Tarsons earmarks funds from IPO to double capacity at its Panchla facility
News | October 12, 2021

Tarsons earmarks funds from IPO to double capacity at its Panchla facility

An amount of Rs. 70.9 crore has been earmarked for funding capital expenditure for the proposed expansion


Algorithm to calculate number of years one lives with good health
Healthcare | October 12, 2021

Algorithm to calculate number of years one lives with good health

In collaboration with RAND Europe, the Vitality calculator predicts an individual's healthspan and future health risks


Medtronic’s robotic-assisted surgery system receives European CE mark
Medical Device | October 12, 2021

Medtronic’s robotic-assisted surgery system receives European CE mark

In Western Europe, about 2% of procedures are done robotically while the majority, approximately 65%, are open surgery


Intas launches the world's first SB-100mg Itraconazole
Drug Approval | October 12, 2021

Intas launches the world's first SB-100mg Itraconazole

Conventional Itraconazole mainstay drug to fight fungal infection has high result variance and low patient compliance because of dosing dependence upon food, acidic beverage and antacid consumption


Sai Life Sciences presents its midterm report
News | October 11, 2021

Sai Life Sciences presents its midterm report

The company has enabled a transformation across three core areas with an investment target of US $ 150 million


AstraZeneca India launches solar project to achieve sustainability goals
Sustainability | October 11, 2021

AstraZeneca India launches solar project to achieve sustainability goals

The company will shift 100 percent of its energy use to renewable sources for both power and heat by 2025 in order to achieve carbon neutrality


IDFC FIRST Bank & Banyan Academy launch Centre for Trauma Studies & Innovation
Healthcare | October 11, 2021

IDFC FIRST Bank & Banyan Academy launch Centre for Trauma Studies & Innovation

Through this initiative, the Centre for Trauma will create curriculums and facilitate trauma-related courses for healthcare professionals at both urban and grassroot levels


Kaneka Covid-19 kits detect all four variants simultaneously
Medical Device | October 11, 2021

Kaneka Covid-19 kits detect all four variants simultaneously

The test kit uses a reagent developed using Kaneka's molecular testing-related technologies


Merck and Ridgeback seek EUA from U.S. FDA for molnupiravir
News | October 11, 2021

Merck and Ridgeback seek EUA from U.S. FDA for molnupiravir

If authorized, molnupiravir could be the first oral antiviral medicine for the treatment of Covid-19


Tezepelumab granted Orphan Drug Designation in the US
Biotech | October 09, 2021

Tezepelumab granted Orphan Drug Designation in the US

Tezepelumab has been granted Orphan Drug Designation (ODD) in the US by the U.S. Food and Drug Administration (FDA) for the treatment of eosinophilic esophagitis (EoE)